PE20091192A1 - Composiciones farmaceuticas que comprenden laxantes y antiespumantes - Google Patents
Composiciones farmaceuticas que comprenden laxantes y antiespumantesInfo
- Publication number
- PE20091192A1 PE20091192A1 PE2008001615A PE2008001615A PE20091192A1 PE 20091192 A1 PE20091192 A1 PE 20091192A1 PE 2008001615 A PE2008001615 A PE 2008001615A PE 2008001615 A PE2008001615 A PE 2008001615A PE 20091192 A1 PE20091192 A1 PE 20091192A1
- Authority
- PE
- Peru
- Prior art keywords
- laxants
- composition
- acidolous
- preferibly
- peristalysm
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
SE REFIERE A UNA COMPOSICION QUE COMPRENDE UN LAXANTE TAL COMO MACROGOLES, LACTULOSA, SORBITOL, MANITOL, XILITOL, ENTRE OTROS; Y UN ANTIESPUMANTE TAL COMO DIMETICONA Y SIMETICONA. DICHA COMPOSICION TAMBIEN PUEDE COMPRENDER UN PRINCIPIO ACTIVO SELECCIONADO DEL GRUPO QUE INCLUYE LOS LAXANTES QUE TIENEN UN EFECTO ANTIABSOCION Y SECRETAGOGO, Y LOS LAXANTES QUE ESTIMULAN EL PERISTALTISMO DEL INTESTINO, PREFERIBLEMENTE DEL GRUPO QUE INCLUYE ANTRAGLICOSIDO, ANTRAQUINONAS, EMODINAS, ACIDO RICINOLEICO, ACEITE DE RICINO, LAXANTES DIFENOLICOS, ACIDOS BILIARES Y COLAGOGOS. SE REFIERE TAMBIEN A UN METODO DE PREPARACION DE UNA COMPOSICION FARMACEUTICA. DICHA COMPOSICION ESTIMULA LA ACTIVIDAD DEL PERISTALTISMO INTESTINAL SIENDO DE UTILIDAD PARA EL TRATAMIENTO DEL ESTRENIMIENTO
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07018665 | 2007-09-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20091192A1 true PE20091192A1 (es) | 2009-08-02 |
Family
ID=40044033
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2008001615A PE20091192A1 (es) | 2007-09-22 | 2008-09-16 | Composiciones farmaceuticas que comprenden laxantes y antiespumantes |
Country Status (7)
Country | Link |
---|---|
AR (1) | AR068530A1 (es) |
CL (1) | CL2008002758A1 (es) |
DE (1) | DE112008002398A5 (es) |
PE (1) | PE20091192A1 (es) |
TW (1) | TW200930385A (es) |
UY (1) | UY31343A1 (es) |
WO (1) | WO2009036906A1 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005099821A1 (en) * | 2004-04-13 | 2005-10-27 | Boehringer Ingelheim International Gmbh | Use of simethicone in constipated patients |
GB0913295D0 (en) | 2009-07-30 | 2009-09-02 | Norgine Bv | Improvements in and relating to pharmaceutical compositions |
DE102012024434A1 (de) * | 2012-12-14 | 2014-06-18 | Regalismons S.A. | Verstärkung der entschäumenden Wirkung von Polysiloxanen, zugehöriger Zusammensetzungen und Lösungen |
EP2898893A1 (en) * | 2014-01-23 | 2015-07-29 | Miklos Varhalmi | Improved cholagogue compositions for treating biliary and digestive tract discomfort |
JP6501923B2 (ja) * | 2015-06-22 | 2019-04-17 | シーティーシー バイオ インコーポレイテッド | 腸管洗浄用の下剤組成物 |
IT201700108033A1 (it) * | 2017-09-27 | 2019-03-27 | Neilos S R L | Composizione per il trattamento della costipazione |
EP3572068A1 (en) | 2018-05-22 | 2019-11-27 | RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.p.a. | New salt of cysteamine for the preparation of highly respirable particles |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7767203B2 (en) * | 1998-08-07 | 2010-08-03 | Ganeden Biotech, Inc. | Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption |
CN1288730A (zh) * | 1999-09-07 | 2001-03-28 | 麦克内尔-Ppc股份有限公司 | 轻泻组合物 |
WO2005099821A1 (en) * | 2004-04-13 | 2005-10-27 | Boehringer Ingelheim International Gmbh | Use of simethicone in constipated patients |
-
2008
- 2008-09-09 DE DE112008002398T patent/DE112008002398A5/de not_active Withdrawn
- 2008-09-09 WO PCT/EP2008/007346 patent/WO2009036906A1/de active Application Filing
- 2008-09-16 CL CL2008002758A patent/CL2008002758A1/es unknown
- 2008-09-16 PE PE2008001615A patent/PE20091192A1/es not_active Application Discontinuation
- 2008-09-16 UY UY31343A patent/UY31343A1/es not_active Application Discontinuation
- 2008-09-19 TW TW097135919A patent/TW200930385A/zh unknown
- 2008-09-22 AR ARP080104115A patent/AR068530A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
TW200930385A (en) | 2009-07-16 |
UY31343A1 (es) | 2009-03-31 |
CL2008002758A1 (es) | 2009-08-14 |
AR068530A1 (es) | 2009-11-18 |
WO2009036906A1 (de) | 2009-03-26 |
DE112008002398A5 (de) | 2010-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20091192A1 (es) | Composiciones farmaceuticas que comprenden laxantes y antiespumantes | |
CL2020000747A1 (es) | Formulaciones de niraparib. | |
WO2016042163A3 (en) | Ophthalmic drug compositions | |
ECSP14012676A (es) | Compuestos de carbamato y preparación y uso de los mismos | |
AR084473A1 (es) | Composiciones farmaceuticas de (r) 1-(2,2-difluorobenzo[d][1,3]dioxol-5-il)-n-(1-(2,3-dihidroxipropil)-6-fluoro-2-(1-hidroxi-2-metilpropan-2-il)-1h-indol-5-il)ciclopropanecarboxamida | |
CL2012003211A1 (es) | Compuestos derivados de lactamas sustituidas con piperidinilo, moduladores de gpr119; proceso para preparar los compuestos; composicion farmaceutica que comprende a los compuestos; y uso de los compuestos en la preparacion de medicamentos para el tratamiento o prevencion de diabetes tipo 2, obesidad y condiciones relacionadas | |
CL2013000714A1 (es) | Compuestos derivados de lactamas sustituidas con piperidinilo, moduladores de gpr119; proceso de preparacion; composicion farmaceutica que los comprende; metodo de tratamiento; y uso del compuesto para tratar enfermedades tales como diabetes tipo 2, sindrome metabolico, dislipidemia, hipertension y esquizofrenia, entre otras. | |
CO6771417A2 (es) | Antagonistas del receptor de ácido lisofosfatidico y su uso en el tratamiento de fibrosis | |
GT201200024A (es) | Formulación subcutánea de anticuerpo anti-her2 | |
UY32874A (es) | Compuestos y composiciones como moduladores de la actividad de tlr | |
CL2011000144A1 (es) | Compuestos derivados de benzo (1,4) dioxin-2-ilmetil-sulfamida; composiciones farmaceuticas que los contienen; proceso para prepararlos y uso en el tratamiento de la ansiedad, epilepsia, dolor, abuso de sustancias, trastornos relacionados, entre otros. | |
WO2011116139A3 (en) | Improved pharmaceutical compositions comprising cck- 8 and methods of delivery | |
CO6410278A2 (es) | Disoluciones pediátricas que continen un beta-bloqueante | |
CO6710926A2 (es) | Compuestos de n-heteroarilo | |
CL2009000381A1 (es) | Compuestos derivados de tiazol o tiazol-5-carboxamida, inhibidores de la actividad estearoil-coa-desaturasa humana (scd); composicion farmaceutica; y uso para el tratamiento de un trastorno o enfermedad mediada por las enzimas de scd, tal como diabetes, obesidad, enfermedad cardiovascular, lipidos elevados, entre otras. | |
EA201190161A1 (ru) | Способ получения твердых лекарственных форм солифенацина и его фармацевтически приемлемых солей для перорального введения | |
BR112012015433A2 (pt) | composição farmacêutica substancialmente anidra para aplicação cutânea | |
PE20091949A1 (es) | Formulacion farmaceutica solida con liberacion retardada | |
CL2017001024A1 (es) | Formulación de buprenorfina inyectable | |
CL2009001366A1 (es) | Compuestos derivados de heterociclil-sulfonamidas con un grupo de cabeza de heterociclo y oxadiazolona; composicion farmaceutica y su proceso de preparacion; y su uso para el tratamiento y/o prevencion de trastornos del metabolismo de acidos grasos y de la glucosa, tal como diabetes mellitus, resistencia a la insulina, dislipidemias, entre otras. | |
BR112017025395A2 (pt) | formulações farmacêuticas para liberação prolongada de sebacoil éster de dinalbufina | |
BRPI0512357A (pt) | composições compreendendo estrÈncio e vitamina d e usos destas | |
AR077987A1 (es) | Combinacion farmaceutica que comprende 6-dimetilaminometil-1-(3-metoxifenil)-ciclohexano-1,3-diol o 6-dimetilaminometil-1-(3-hidroxifenil)-ciclohexano-1,3-diol y un antiepileptico | |
MX2020003697A (es) | Formulaciones farmaceuticas que comprenden un agonista del receptor opioide como ingredientes activos, metodos de fabricacion y usos terapeuticos de las mismas. | |
ECSP13013095A (es) | Composición farmacéutica que comprende fexofenadina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application declared void or lapsed |